End-of-day quote
Shanghai Stock Exchange
-
2022-06-30
11.88
CNY
-0.25%
06/09 Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd. CI
04/26 Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares. CI
04/26 Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan. CI
Quotes 5-day view End-of-day quote Shanghai Stock Exchange
06/27/2022
06/28/2022
06/29/2022
06/30/2022
07/01/2022
Date
12.09
12.15
11.98
11.91
11.88
Last
9557027
5921633
8268706
9278354
4913041
Volume
-0.17%
+0.50%
-1.40%
-0.58%
-0.25%
Change
Estimated financial data (e) CNY USD
Sales 2022
139 B
20 808 M
20 808 M
Net income 2022
2 369 M
353 M
353 M
Net Debt 2022
8 880 M
1 325 M
1 325 M
P/E ratio 2022
9,40x
Yield 2022
3,70%
Sales 2023
157 B
23 500 M
23 500 M
Net income 2023
2 783 M
415 M
415 M
Net Debt 2023
8 607 M
1 284 M
1 284 M
P/E ratio 2023
7,99x
Yield 2023
4,00%
Capitalization
21 913 M
3 270 M
3 270 M
EV / Sales 2022
0,22x
EV / Sales 2023
0,19x
Nbr of Employees
29 338
Free-Float
36,1%
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Company’s products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal...
Ratings of Jointown Pharmaceutical Group Co., Ltd
All news about JOINTOWN PHARMACEUTICAL GROUP CO., LTD
06/09 Amcare Lab announced that it has received $31 million in funding from Jointown Pharmace.. CI
04/26 Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million .. CI
04/26 Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan. CI
04/25 Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter E.. CI
04/25 Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended.. CI
04/18 Binhui Biopharm announced that it has received $47.1 million in funding from Yangtze Ri.. CI
2021 Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months En.. CI
2021 Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ende.. CI
2021 Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter .. CI
2021 Tranche Update on Jointown Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announc.. CI
2021 Jointown Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 16, 202.. CI
2021 JOINTOWN PHARMACEUTICAL : Swiss Logistics Firm Kuehne+Nagel Partners with Jointown to Mana..MT
2021 KUEHNE + NAGEL INTERNATIONAL : Kühne + Nagel International Signs Logistics Deal With China..MT
2021 JOINTOWN PHARMACEUTICAL : ADB, Jointown Sign EUR30 Million Loan to Expand Pharmaceutical D..AQ
2021 Sinovac COVID-19 vaccine unit struggles to add new hires as holiday nears RE
News in other languages on JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Chart JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Short Term Mid-Term Long Term Trends Neutral Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
11,88 CNY
Average target price
13,40 CNY
Spread / Average Target
12,8%
Please enable JavaScript in your browser's settings to use dynamic charts.